Best Practices To Avoid Common Pitfalls In Plasmid Sourcing


Cell and gene therapy continues to be on the rise, and the number of available CDMOs to support the development and manufacture of your advanced therapy also continues to rise. However, a CDMO partner with little experience in plasmid production could delay your timeline and reduce your potential to be first to market.

Ensuring that your CDMO has a safety stock of long-lead items as well as template batch records ensures a prompt start to production and increased consistency. Setting realistic and optimal expectations for communication timelines and cost proposals is also of high-importance in establishing an optimal CDMO relationship. Explore the benefits of partnering with an experienced CDMO and learn the best practices to ensure seamless plasmid production.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online

Ajinomoto Bio-Pharma Services